Which lymphomas can cause pancytopenia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lymphomas Most Commonly Associated with Pancytopenia

The lymphomas most frequently causing pancytopenia are T-cell and NK-cell lymphomas (particularly peripheral T-cell lymphomas, hepatosplenic T-cell lymphoma, and subcutaneous panniculitis-like T-cell lymphoma), diffuse large B-cell lymphoma (DLBCL), and intravascular large B-cell lymphoma, with these entities triggering hemophagocytic lymphohistiocytosis (HLH) or directly infiltrating bone marrow. 1

Primary Lymphomas Causing Pancytopenia

T-Cell and NK-Cell Lymphomas (Most Common Overall)

T-cell malignancies represent 35% of lymphoma-associated HLH cases in adults and are the predominant trigger in Asian populations 1. The specific subtypes most likely to cause pancytopenia include:

  • Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS): Presents with constitutional symptoms, hepatosplenomegaly, and progressive pancytopenia even without peripheral lymphadenopathy 2, 3
  • Hepatosplenic T-cell lymphoma: Characteristically presents with massive splenomegaly and severe pancytopenia, often requiring splenectomy for both diagnosis and cytopenia management 4
  • Subcutaneous panniculitis-like T-cell lymphoma: Particularly associated with HLH-triggered pancytopenia 1
  • Extranodal NK/T-cell lymphoma, nasal type: Can trigger HLH leading to pancytopenia 1

B-Cell Lymphomas

Diffuse large B-cell lymphoma (DLBCL) is the most frequent B-cell lymphoma causing pancytopenia, representing 32% of B-cell lymphomas associated with HLH and is the predominant trigger in Western countries 1. DLBCL can cause pancytopenia through:

  • Direct bone marrow infiltration (primary bone marrow DLBCL is rare but presents with severe pancytopenia) 5
  • Triggering HLH with secondary cytopenias 1

Intravascular large B-cell lymphoma deserves special mention as it characteristically presents with isolated pancytopenia without lymphadenopathy, making diagnosis particularly challenging 6.

Other Notable Lymphomas

  • Hodgkin lymphoma: Accounts for 6% of malignancy-triggered HLH cases 1
  • Hairy cell leukemia: Classic presentation includes splenomegaly, pancytopenia, and bone marrow fibrosis 7, 8
  • Lymphoplasmacytic lymphoma (Waldenström's macroglobulinemia): Can rarely present with pancytopenia, though this is not the typical presentation 9

Mechanisms of Pancytopenia

Lymphomas cause pancytopenia through three primary mechanisms:

  1. Hemophagocytic lymphohistiocytosis (HLH): Malignancy-triggered HLH occurs when lymphoma cells secrete cytokines (interferon-γ, interleukin-6) driving hyperinflammation and hemophagocytosis 1

  2. Direct bone marrow infiltration: Lymphoma cells replace normal hematopoietic tissue, with bone marrow biopsy showing lymphomatous involvement 5, 10

  3. Hypersplenism: Massive splenomegaly from lymphomatous infiltration causes peripheral sequestration and destruction of blood cells 4

Critical Diagnostic Considerations

Pancytopenia with constitutional symptoms (fever, night sweats, weight loss) and hepatosplenomegaly should prompt immediate evaluation for lymphoma, even in the absence of peripheral lymphadenopathy 2, 3. The diagnostic workup must include:

  • Bone marrow aspirate and biopsy with immunophenotyping and flow cytometry
  • T-cell receptor gene rearrangement studies for suspected T-cell lymphomas 3
  • Ferritin, soluble CD25, and fibrinogen levels to assess for HLH 1
  • 18F-FDG PET/CT to identify occult lymphomatous involvement 4

Common pitfall: Intravascular lymphoma and some T-cell lymphomas may show minimal lymphoma cells on routine bone marrow histology, requiring immunophenotyping and molecular studies for diagnosis 3, 6. Do not exclude lymphoma based on initial negative bone marrow examination if clinical suspicion remains high.

Age matters: In adults, nearly half of HLH cases are triggered by malignancy, with the likelihood increasing with age 1. In children, T-cell malignancies predominate as triggers 1.

The platelet count serves as a rapid marker of disease activity in HLH-associated pancytopenia, with drops indicating disease flares 1.

Related Questions

In a 39-year-old man with normochromic normocytic anemia, leukopenia, thrombocytopenia, hyperglycemia, and hypocalcemia, what is the appropriate next step in evaluation and management?
What is the next step in managing pancytopenia in a patient with pulmonary tuberculosis (TB) on anti-tuberculosis treatment (ATT) with low vitamin B12 levels and no improvement in CBC after 12 days of intravenous B12 supplementation?
What is the appropriate diagnostic and therapeutic approach for a 33-year-old male with a 7‑week history of generalized weakness, chronic alcohol use, mild anemia, low vitamin B12 and vitamin D, mild hyperbilirubinemia, elevated AST/ALT, markedly elevated alkaline phosphatase and GGT, normal renal function, and dyslipidemia?
How to approach a patient with fatigue, constipation, and pedal edema who has pancytopenia on blood workup?
What is the appropriate urgent management for a 30‑year‑old female with hematocrit 23 %, hemoglobin 9 g/dL, pancytopenia, and a white‑blood‑cell count of 2 ×10⁹/L?
In a 40‑week pregnant woman 14 hours after Cervidil (dinoprostone) removal with a cervical dilation of 1.5 cm and previously regular contractions every 8–12 minutes, what does a decrease in contraction frequency indicate and what actions should be taken?
Which medication among Wellbutrin (bupropion), Seroquel (quetiapine), and buspirone most commonly causes weight gain?
What are the indications, contraindications, dosing guidelines, and monitoring recommendations for prescribing fluoxetine?
What medication recommendations are appropriate for a patient with a premature atrial contraction (PAC) burden of 11.78%?
What is the appropriate workup for a possible deviated septum?
How is the interferon signature measured?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.